Pt Hetzer Medical Stock Beta
| MEDS Stock | 50.00 0.00 0.00% |
PT Hetzer Medical fundamentals help investors to digest information that contributes to PT Hetzer's financial success or failures. It also enables traders to predict the movement of MEDS Stock. The fundamental analysis module provides a way to measure PT Hetzer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PT Hetzer stock.
MEDS |
PT Hetzer Medical Company Beta Analysis
PT Hetzer's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, PT Hetzer Medical has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The beta for all Indonesia stocks is 100.0% lower than that of the firm.
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
MEDS Fundamentals
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.12 % | |||
| Shares Outstanding | 1.56 B | |||
| Shares Owned By Insiders | 8.00 % | |||
| Price To Sales | 5.97 X | |||
| Revenue | 43.99 B | |||
| Gross Profit | 53.98 B | |||
| EBITDA | 7.68 B | |||
| Book Value Per Share | 45.78 X | |||
| Number Of Employees | 25 | |||
| Market Capitalization | 231.25 B |
About PT Hetzer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PT Hetzer Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Hetzer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Hetzer Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.